NICE U-turn for Epidyolex in epilepsy

11 November 2019 - GW Pharma has announced that NICE has recommended Epidyolex (cannabidiol) for two rare, severe forms of ...

Read more →

Prescription drug prices are falling at historic levels thanks to Trump Administration policies

5 November 2019 - While the media continues to claim prescription drug prices are rising, a recent Council of Economic ...

Read more →

NICE International returns to deal with growing overseas enquiries

5 November 2019 - Division will offer an advisory service to international organisations, ministries and government agencies. ...

Read more →

GE Healthcare announces U.S. FDA approval of macrocyclic MRI contrast agent Clariscan (gadoterate meglumine) injection for intravenous use

4 November 2019 - Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now ...

Read more →

FDA approves Fluzone High-Dose quadrivalent (influenza vaccine) for adults 65 years of age and older

4 November 2019 - Will be available in fall 2020, in time for the 2020-2021 flu season. ...

Read more →

Sandoz receives US FDA approval for long-acting oncology supportive care biosimilar Ziextenzo (pegfilgrastim-bmez)

5 November 2019 - Ziextenzo is indicated to decrease the incidence of febrile neutropenia, one of the most serious side effects ...

Read more →

RedHill Biopharma announces FDA approval of Talicia for treatment of H. pylori in adults

4 November 2019 - RedHill plans to launch Talicia in the U.S. in Q1/2020 for the treatment of H. pylori infection ...

Read more →

FDA verdict on Biogen’s Alzheimer’s drug likely to be a ‘political decision,’ analyst says

4 November 2019 - Federal regulators may buckle to public and political pressure to approve Biogen’s experimental Alzheimer’s drug, according to ...

Read more →

Obscure model puts a price on good health—and drives down drug costs

4 November 2109 - Concept called QALY places dollar value on the health medicines can restore; ‘starting to influence decision-making’. ...

Read more →

A cash grab': States declare war with health funds over patients in public hospitals

4 November 2019 - State health ministers are demanding a hefty increase to the fee charged to health funds when ...

Read more →

Talking with Tama, a sick toddler who can't access the drug he needs

5 November 2019 - "Hi!" a bright young voice says down the phone. ...

Read more →

New leukaemia medicine means three new cancer drugs funded this year

4 November 2019 - PHARMAC will fund a new leukaemia medicine, which will improve the quality of life for roughly ...

Read more →

PHARMAC funding new leukaemia medicine

4 November 2019 - New Zealanders with chronic lymphocytic leukaemia will have another medicine option available to help them live ...

Read more →

Warren health plan tightens Democrats’ embrace of tax increases

2 November 2019 - A ‘Medicare for all’ proposal would push the boundaries of taxing corporations and the rich to fund ...

Read more →

Hundreds of Kiwis battling leukaemia given hope with funding of new drug

4 November 2019 - Hundreds of Kiwis battling leukaemia cancer have been given hope, with PHARMAC today announcing funding for ...

Read more →

International impact of external reference pricing: should national policy makers care?

3 November 2019 - External reference pricing is widely used to regulate drug prices.  ...

Read more →